$SHCR At $10 a share this company took advantage of crazy valuations SPACS are willing to pay for decent companies. Insiders sold a bunch of stock on the merger at a price North of $3.8 Billion ($10 a share). The shorts and other investors used the public liquidity to sell the stock down to $6.45 or close to a $2.7 Billion valuation less cash on balance sheet of $400. $2.3 Billion for $31 Million in 2021 EBITDA Still crazy expensive. The good news is that the company should grow EBITDA quickly to $100 and the stock can grow into its valuation. Probably a good place to start accumulating some stock if you have a long term perspective.
@johns45 they didnt dump shares though, that was part of the deal for fcac to buy the equity of pre public sharecare. Equity holders got up to 275mm in cash consideration and shcr stock That's been inked in since merger was announced That's like saying shcr insiders sold $401mm worth becuase shcr got $401mm @ closing
@penuschrist This is pretty simple. Shareholders in Sharecare chose to sell 27.5 million shares of their holdings at $10 a share as part of the merger. Some of them had been investors for many years and wanted to free up capital. Others did not want to wait for the lockup to expire 6 months after. Whatever the reasons 7% of existing shareholders sold their stock on the merger the rest converted to SHCR stock. Case closed. Go buy more stock its only expensive now.